Improve gait stability using cane
- Trial ID
- NCT06950255
- Official Title
- Effect of a 3-week Program of Cane Training and Use on Gait of Individuals With Parkinson's Disease: Protocol for a Randomized Controlled Trial
- Goal
- Improve gait stability using cane
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Federal University of Minas Gerais
- Study Type
- INTERVENTIONAL
- Enrollment
- 26 participants
- Conditions
- Parkinson Disease
- Interventions
- Cane, static stretching and health education
Plain-Language Summary
It tests whether a focused 3-week cane training program can improve walking speed, step quality and stability for people with Parkinson's who have slowed or unstable gait. Participants are randomized to supervised training that teaches correct single-point cane timing, placement, weight shift and posture to promote steadier, longer steps, or to a control group doing static stretching and health education; the cane is a mechanical aid used alongside stable Parkinson's medications and does not change how drugs like levodopa work. The trial is looking for adults 40 and older with idiopathic PD at Hoehn and Yahr stages II to IV who can walk independently up to 14 meters at 1.1 m/s or slower, are on stable antiparkinsonian meds for at least 6 months, and can safely use a single-point cane, while people with cognitive impairment, deep brain stimulation, or other major health issues are excluded.
Locations
- Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Cane. It tests whether a focused 3-week cane training program can improve walking speed, step quality and stability for people with Parkinson's who have slowed or unstable gait. Participants are randomized to supervised training that teaches correct single-point cane timing, placement, weight shift and posture to promote steadier, longer steps, or to a control group doing static stretching and health education; the cane is a mechanical aid used alongside stable Parkinson's medications and does not change how drugs like levodopa work. The trial is looking for adults 40 and older with idiopathic PD at Hoehn and Yahr stages II to IV who can walk independently up to 14 meters at 1.1 m/s or slower, are on stable antiparkinsonian meds for at least 6 months, and can safely use a single-point cane, while people with cognitive impairment, deep brain stimulation, or other major health issues are excluded.
- Who can participate?
- Participants must be at least 40 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 4 months.